Legitimacy in bioethics: challenging the orthodoxy

Area of Science:

• Bioethics
• Political Philosophy
• Health Policy Analysis

Background:

• The orthodox view posits that policy legitimacy hinges on democratic deliberation using only public reasons accessible to all stakeholders.
• Prominent scholars like Daniels, Sabin, Gutmann, Thompson, and Fleck support this public reason-based legitimacy model.
• Actual policy-making, exemplified by the Affordable Care Act (ACA) and Health Securities Act (HSA), often deviates from this ideal.

Purpose of the Study:

• To clarify the concept of legitimacy within bioethics discourse.
• To critique the orthodox view of legitimacy by presenting counterexamples from healthcare policy.
• To explore the implications of publicity requirements on justice and healthcare rights.

Main Methods:

• Conceptual analysis of legitimacy in bioethics.
• Case study analysis of the Affordable Care Act (ACA) and Health Securities Act (HSA) policy processes.
• Argumentative critique of the orthodox view, addressing counterarguments and alternative interpretations.

Main Results:

• The orthodox view of legitimacy, requiring strict adherence to public deliberation, faces counterexamples in actual healthcare policy.
• Applying the orthodox view may necessitate unjust sacrifices of healthcare rights to maintain publicity standards.
• Responses defending the orthodox view often require revisions or fail to adequately address the tension between publicity and substantive justice.

Conclusions:

• The orthodox view of policy legitimacy may be too stringent, potentially undermining justice and healthcare rights.
• Actual policy processes, like the ACA, can achieve legitimacy despite not perfectly aligning with the public deliberation model.
• A greater role for substantive considerations, beyond just publicity, is likely necessary for a robust understanding of policy legitimacy.